Active substances
Enalapril + Hydrochlorothiazide
- SFDA 1
- US FDA 8
- Health Canada 3
- US price lines 2
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CO-RENITEC | 20,12.5 mg,mg | Tablet · Oral use | 30 Blister | SAR 66.50 | NCE · Prescription | N.V. Organon | Valid |
Indications — CHI Daman Drug Formulary
HYPERTENSION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| VASERETIC | 10MG;25MG; 5MG;12.5MG | tablet · oral | BAUSCH | Prescription | 31 Oct 1986 |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 5MG;12.5MG; 10MG;25MG | tablet · oral | TARO PHARM INDS | Prescription | 18 Sep 2001 |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 5MG;12.5MG; 10MG;25MG | tablet · oral | SENORES PHARMS | Prescription | 15 Oct 2001 |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 5MG;12.5MG; 10MG;25MG | tablet · oral | RISING | Discontinued | 18 Sep 2001 |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 5MG;12.5MG; 10MG;25MG | tablet · oral | COSETTE PHARMS NC | Discontinued | 18 Sep 2001 |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 5MG;12.5MG; 10MG;25MG | tablet · oral | CHARTWELL RX | Discontinued | 19 Sep 2001 |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 5MG;12.5MG; 10MG;25MG | tablet · oral | IVAX SUB TEVA PHARMS | Discontinued | 25 Mar 2003 |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 5MG;12.5MG; 10MG;25MG | tablet · oral | MPP PHARMA | Discontinued | 27 Oct 2004 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ENALAPRIL MALEATE/HCTZ | 02352923 | 5 MG; 12.5 MG | TABLET · ORAL | AA PHARMA INC |
| ENALAPRIL MALEATE/HCTZ | 02352931 | 25 MG; 10 MG | TABLET · ORAL | AA PHARMA INC |
| VASERETIC | 00657298 | 8 MG; 25 MG | TABLET · ORAL | ORGANON CANADA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ENALAPRIL-HYDROCHLOROTHIAZIDE 10-25 MG TABLET | $0.20863 | per EA | 23 Sep 2026 |
| US NADAC | ENALAPRIL-HYDROCHLOROTHIAZIDE 5-12.5 MG TAB | $0.16989 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Enalapril 20mg / Hydrochlorothiazide 12.5mg tablets | £23.06 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.